aid: aardvark-therapeutics
name: Aardvark Therapeutics
description: 'Aardvark Therapeutics, Inc. is a Nasdaq-listed (AARD) clinical-stage biopharmaceutical
  company developing novel small-molecule therapies designed to inhibit hunger and treat metabolic
  disease. Its lead candidate, ARD-101, is an oral, gut-restricted agonist of bitter taste receptors
  (TAS2Rs) on the luminal side of the intestine, which triggers the release of satiety hormones to
  suppress hunger signaling; it has been evaluated for hyperphagia associated with Prader-Willi
  Syndrome, including the Phase 3 HERO trial, as well as in obesity and hypothalamic obesity. The
  company operates purely as a drug-development organization: its public web presence consists of
  science, programs, team, news and investor-relations material, and it publishes no developer
  program, public API, SDK, webhook surface or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/aardvark-therapeutics/refs/heads/main/apis.yml
image: https://i0.wp.com/aardvarktherapeutics.com/wp-content/uploads/2022/11/d-footer-logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Drug Development
- Rare Disease
- Metabolic Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Aardvark Therapeutics is a clinical-stage biopharmaceutical company whose product is a drug
    (ARD-101), not software — its entire site is a seven-page WordPress marketing presence
    (home, science, programs, team, news, contact, legal) with no developer, API or documentation
    section anywhere in its sitemap.
  evidence:
    - url: https://aardvarktherapeutics.com/openapi.json
      status: 404
    - url: https://aardvarktherapeutics.com/developers
      status: 404
    - url: https://aardvarktherapeutics.com/.well-known/agent-card.json
      status: 404
    - url: https://aardvarktherapeutics.com/page-sitemap.xml
      status: 200
    - url: https://api.github.com/orgs/aardvark-therapeutics
      status: 200
  checked: '2026-08-06'
common:
- type: DomainSecurity
  url: security/aardvark-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/aardvark-therapeutics-llms.txt
- type: Website
  url: https://aardvarktherapeutics.com/
- type: PrivacyPolicy
  url: https://aardvarktherapeutics.com/legal/privacy-policy/
- type: TermsOfService
  url: https://aardvarktherapeutics.com/legal/terms-of-use/
- type: Contact
  url: https://aardvarktherapeutics.com/contact/
- type: News
  url: https://aardvarktherapeutics.com/in-the-news/
- type: InvestorRelations
  url: https://ir.aardvarktherapeutics.com/
- type: GitHubOrganization
  url: https://github.com/Aardvark-Therapeutics
- type: SecondaryMarket
  url: https://forgeglobal.com/aardvark-therapeutics_stock/